Non-alcoholic fatty liver disease(NAFLD) is an umbrella term to describe the entire spectrum of this common liver disease. In patients with NAFLD, especially those with non-alcoholic steatohepatitis(NASH), most often have one or more components of the metabolic syndrome, but this is not ...
Visceral fat refers to the fat that accumulates deep within the abdominal cavity, surrounding the internal organs such as the liver, pancreas, and intestines. Unlike subcutaneous fat, which is found just beneath the skin, visceral fat is located deeper within the body. Its major role is to for...
Lifestyle interventions (including diet, exercise and behavioural changes) are the cornerstone of obesity management with diverse benefits, but even the most intensive lifestyle interventions result in up to 10% mean weight loss (WL) and weight maintenance remains a challenge, as 80% of WL is ex...
liver-related mortality has become one of the leading causes of non-AIDS related death in this patient population. The liver possesses a remarkable regenerative capacity but undergoes complex biological changes in response to aging and inflammation that result in decreased cellular regeneration and a ti...
1Citations Abstract Physical activity is a key determinant of metabolic control and is commonly recommended for people with non-alcoholic fatty liver disease (NAFLD), usually alongside weight loss and dietary change. Physical activity and exercise have both been shown to improve liver health in NAFLD...
(NCT03819153), and this trial is expected to be completed at the end of 2024. Planned meta-analyses [42] and other studies are also underway. Studies investigating the protective effects of GLP-1 receptor agonists on cognitive dysfunction [43,44], nonalcoholic fatty liver disease (NAFLD)/non...
A systematic PubMed database search was conducted highlighting that common mechanisms are involved in many of the local and systemic manifestations of NAFLD, leading to an increased cardiovascular risk, and IBS, leading to microbial dysbiosis, impaired intestinal barrier and altered intestinal motility....
Human METTL16 is a N(6)-methyladenosine (m(6)A) methyltransferase that targets pre-mRNAs and various non-coding RNAs. EMBO Rep. 2017;18(11):2004–14.10.15252/embr.201744940Search in Google Scholar PubMed PubMed Central [24] Brown JA, Kinzig CG, DeGregorio SJ, Steitz JA. ...
Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: What is the prevalence and risk factors?. Arab J Gas- troenterol. 2014;15(1):12-5. doi: 10.1016/j.ajg.2014.01.008. [PubMed: 24630507].Almobarak AO, Barakat S, Khalifa MH, Elhoweris MH, Elhassan TM, Ahmed MH....
PubMed database search was conducted highlighting that common mechanisms are involved in many of the local and systemic manifestations of NAFLD,leading to an increased cardiovascular risk,and IBS,leading to microbial dysbiosis,impaired intestinal barrier and altered intestinal motility.It is not known ...